Bradley L. Campbell, President and CEO at AMICUS THERAPEUTICS, INC. (FOLD), sold 22,500 shares at $14.35 ($323K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Scheduled sale ($323k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FOLD | SELL | 2025-12-03 | $292K | — | Filing → |
| FOLD | SELL | 2025-11-26 | $293K | — | Filing → |
| FOLD | SELL | 2025-02-21 | $4K | — | Filing → |